Merck & Co., Inc. (NYSE:MRK)

tired frustrated unhappy business person

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Merck & Co. (NYSE: MRK) saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial for the treatment of Alzheimer’s disease. ...
Read Full Story »
thinkstockphotos-522646895

Apple, JPMorgan Dominate DJIA on Tuesday

February 14, 2017: Markets opened mixed Tuesday as investors and traders stepped back a bit from the pace of the last few days' trading. Although the three major indexes traded ...
Read Full Story »
Pair of dice

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
Medical vaccine in shoulder, vaccination

Why Merck’s Q4 Earnings Aren’t Enough for Investors

Merck & Co. (NYSE: MRK) reported its fourth-quarter financial results before the markets opened on Thursday. The company posted $0.89 in earnings per share (EPS) and $10.12 billion in revenue, ...
Read Full Story »
Dow

The Top 2 Dow Stocks Reporting on Thursday

24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on Thursday: Merck & Co. Inc. (NYSE: MRK) and Visa Inc. (NYSE: ...
Read Full Story »
Profit or Loss

What to Expect From Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week. Five of the Dow stocks are reporting next ...
Read Full Story »
Prescription drugs

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
market crash

GE, Exxon, Boeing Sink DJIA on Monday

January 23, 2017: Markets opened slightly higher Monday but shares soon dipped below the break-even line and spent the rest of the day in the red. Most sectors are trading in ...
Read Full Story »
stock market

Merck, P&G Lead Dow Stocks Higher Friday

January 20, 2017: Markets opened higher Friday as investors got little guidance from economic data (there was none) or earnings reports. Equities traded higher in the morning and dipped beginning ...
Read Full Story »
market crash

Exxon Mobil, Merck Weigh on DJIA Thursday

January 19, 2017: Markets opened slightly higher Thursday as investors appear to be waiting to what President-elect Donald Trump has to say in his inauguration speech on Friday. Only the industrials ...
Read Full Story »
white pills

Merck Is Best Performing DJIA Stock So Far in 2017

The Dow Jones Industrial Average came within a hair of reaching the 20,000 mark on January 6 but has since dropped back to close Friday at 19,885.73. Since the November ...
Read Full Story »
Medicine pills

Why 3 Analysts Upgraded Merck Simultaneously

It may seem hard to believe that a Big Pharma drug stock might be a favorite for the year ahead when the attacks against drug pricing and competition do not ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: AK Steel, Merck, Twitter, US Steel, Disney, Xerox and More

Stocks were soft on Thursday morning but the directional move is not so great that there is much conviction set for the day. Trump's press conference on Wednesday created some ...
Read Full Story »
thinkstockphotos-522646895

Merck, IBM Pace DJIA to Wednesday Gain

January 11, 2017: Markets opened slightly higher Wednesday as politics ruled the news. Energy was today's best performing sector even though the EIA inventory report was hugely bearish. Countering the ...
Read Full Story »